Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Second UK lockdown? COVID hospital admissions double every eight days

Published 2020-09-18, 03:17 a/m
Updated 2020-09-18, 04:18 a/m
© Reuters. FILE PHOTO: Outbreak of the coronavirus disease (COVID-19) in London

By Guy Faulconbridge and Kate Holton

LONDON (Reuters) - Britain's health minister said on Friday that the novel coronavirus was accelerating across the country, with hospital admissions doubling every eight days, but refused to say if another national lockdown would be imposed next month.

The United Kingdom has reported the fifth largest number of deaths from COVID-19 in the world, after the United States, Brazil, India and Mexico, according to data collected by Johns Hopkins University of Medicine.

Asked repeatedly by Sky News about the prospect of a second national lockdown next month, Health Secretary Matt Hancock said that a lockdown was a last resort, but that the government would do whatever it takes to tackle the virus.

"The number of people in hospital is doubling every eight days or so ... we will do what it takes to keep people safe," Hancock said. "We keep these things under review."

Asked about a second lockdown, he said: "I can't give you that answer now."

COVID-19 cases started to rise again in Britain in September, with between 3,000 and 4,000 positive tests recorded daily in the last week. This is still some way behind France, which is seeing more than 10,000 new cases a day.

On Thursday, Britain recorded 21 deaths from the disease, taking the total under the government's accounting method to 41,705. Key statistics on the prevalence of the virus are due later on Friday.

More than 10 million people in the United Kingdom are already in local lockdown and the London Evening Standard said figures due for release on Friday will show a sharp rise in COVID cases in London, putting Britain's capital at risk of restrictions on socialising over the next two weeks.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Prime Minister Boris Johnson was criticised by opposition politicians for his initial response to the outbreak and the government has struggled to ensure sufficient testing in recent weeks.

Asked by LBC radio why the testing system was such a "shambles", Hancock said Dido Harding, who is in charge of the system, had done an "an extraordinary job."

A COVID-19 test known as DnaNudge that gives results in just over an hour and which requires no laboratory was accurate in almost all cases, according to an academic review in the Lancet.

"The critical thing in terms of usefulness is that the machine doesn't need to be in a lab - it is about the size of a shoebox - therefore you can put one say in an A&E department and they can know whether people coming in have got the coronavirus or not," Hancock said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.